Stratos Wealth Partners, Ltd. Sarepta Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$72.25 - $168.95 $88,939 - $207,977	-1,231 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$125.56 - $178.74 $24,735 - $35,211	-197 Reduced 13.8%	1,231 $210,000
Q3 2020 Oct 29, 2020	SELL	$127.12 - $172.34 $11,186 - $15,165	-88 Reduced 5.8%	1,428 $201,000
Q2 2020 Jul 28, 2020	BUY	$93.0 - $171.7 $140,988 - $260,297	1,516 New	1,516 $243,000
Q1 2020 May 04, 2020	SELL	$82.38 - $131.64 $188,238 - $300,797	-2,285 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$76.53 - $135.58 $173,723 - $307,766	2,270 Added 15133.33%	2,285 $295,000
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $1,092 - $2,353	15 New	15 $202,000
Q4 2018 Feb 08, 2019	SELL	$97.32 - $148.76 $37,468 - $57,272	-385 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$115.31 - $161.51 $44,394 - $62,181	385 New	385 $62,000
Q2 2018 Aug 13, 2018	SELL	$71.74 - $153.69 $35,870 - $76,845	-500 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$54.02 - $82.27 $27,010 - $41,135	500 New	500 $37,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.